These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1803067)

  • 1. Acid-promoted epimerization of arbaprostil, 15(R)-15-methylprostaglandin E2, elicits gastric antisecretory activities in rats.
    Takanashi H; Kawabe Y; Akima M
    Jpn J Pharmacol; 1991 Dec; 57(4):559-64. PubMed ID: 1803067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antisecretory activity of 15(R)-15-methylprostaglandin E2, arbaprostil, in dogs.
    Takanashi H; Itoh Z
    Jpn J Pharmacol; 1991 Nov; 57(3):447-51. PubMed ID: 1813671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels of the prodrug, arbaprostil, [(15R)-15-methylprostaglandin E2], and its active, antiulcer (15S) epimer in humans after single dose oral administration.
    Cox JW; Bothwell WM; Pullen RH; Wynalda MA; Fitzpatrick FA; VanderLugt JT
    J Pharm Sci; 1986 Nov; 75(11):1107-12. PubMed ID: 3820107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on gastric secretion and various gastric lesions induced in rats.
    Okabe S; Jino H; Nishida A
    Jpn J Pharmacol; 1986 Feb; 40(2):329-37. PubMed ID: 3702150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric antisecretory activity of arbaprostil as affected by gastric pH.
    Reele SB
    Dig Dis Sci; 1985 Jul; 30(7):612-6. PubMed ID: 4006643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastric antisecretory effect of 15(R)-15 methyl PGE2 and 15(S)-15 methyl PGE2 in the rat].
    Mizuta K; Moriga M; Narusawa H; Uchino H; Aono M
    Nihon Shokakibyo Gakkai Zasshi; 1985 Jul; 82(7):1684-92. PubMed ID: 4079086
    [No Abstract]   [Full Text] [Related]  

  • 7. Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally.
    Robert A; Kane G; Reele SB
    Gut; 1981 Sep; 22(9):728-31. PubMed ID: 7297921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of arbaprostil against indomethacin-induced gastric lesions in rats: significance of maintained gastric blood flow.
    Takanashi H; Akima M
    Jpn J Pharmacol; 1992 Jul; 59(3):349-55. PubMed ID: 1434129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies with 15(R)-15-methylprostaglandin E2 (arbaprostil) in rat femoral arterial preparations in vivo and in vitro.
    Takanashi H; Yogo K; Itoh-Inaba H; Akima M
    Gen Pharmacol; 1993 Sep; 24(5):1177-85. PubMed ID: 8270177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiclinic trial evaluating arbaprostil [15(R)-15-methyl prostaglandin E2] as a therapeutic agent for gastric ulcer.
    Euler AR; Popiela T; Tytgat GN; Kulig J; Lookabaugh JL; Phan TD; Kitt MM
    Gastroenterology; 1989 Apr; 96(4):967-71. PubMed ID: 2647578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the synthesized prostaglandin E2-analogue arbaprostil on gastric mucosal lesions in rats.
    Sugiyama S; Kawabe Y; Kuroiwa M; Goto H; Tsukamoto Y; Ozawa T
    Arzneimittelforschung; 1989 Dec; 39(12):1571-3. PubMed ID: 2624606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A report of three multiclinic trials evaluating arbaprostil in arthritic patients with ASA/NSAID gastric mucosal damage. The Upjohn Company Arbaprostil ASA/NSAID Gastric Mucosal Damage Treatment Study Groups.
    Euler AR; Safdi M; Rao J; Jaszewski R; Welsh J; Le V; Raskin J; Fleischmann R; Razzaque M; Champion C
    Gastroenterology; 1990 Jun; 98(6):1549-57. PubMed ID: 2186951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arbaprostil [15(R)-15-methyl prostaglandin E2] in a single nighttime dose of either 50 or 100 micrograms in acute duodenal ulcer.
    Euler AR; Bailey RJ; Zinny MA; Brandon ML; Rousseau B; Ferguson JP; Wood DR; Le VH
    Gastroenterology; 1989 Jul; 97(1):98-103. PubMed ID: 2656368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of NC-1300 and its degradation products on gastric secretion and HCl.ethanol-induced gastric lesions in rats.
    Okabe S; Akimoto Y; Miyake H; Imada J
    Jpn J Pharmacol; 1987 May; 44(1):7-14. PubMed ID: 3626185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 15 (R)-15-methyl prostaglandin E2 does not prevent gastrointestinal bleeding in seriously ill patients.
    Skillman JJ; Lisbon A; Long PC; Silen W
    Am J Surg; 1984 Apr; 147(4):451-5. PubMed ID: 6370007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of central prostaglandin E2 antisecretory effects.
    Barocelli E; Impicciatore M; Seaton J; Conter R; Kauffman G
    Gastroenterology; 1991 Feb; 100(2):320-7. PubMed ID: 1985030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisecretory and antiulcer effects of YM020, a new H+,K(+)-ATPase inhibitor, in rats and dogs.
    Yuki H; Kamato T; Nishida A; Ohta M; Shikama H; Yanagisawa I; Miyata K
    Jpn J Pharmacol; 1995 Jan; 67(1):59-67. PubMed ID: 7745846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally applied histamine increases gastric acid secretion in rats.
    Puurunen J
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul; 338(1):96-8. PubMed ID: 3237254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigastrolesive, gastric antisecretory, diarrheagenic and mucus-stimulating effects in rats following topically applied rioprostil, a synthetic prostaglandin E1 analog.
    Katz LB; Genna T; Scott CK; Rosenthale ME; Shriver DA
    Life Sci; 1987 Sep; 41(13):1591-8. PubMed ID: 3114582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of the urinary metabolites of arbaprostil in the male dog after intravenous administration.
    Thornburgh BA; Shaw SR; Bronson GE; Sinha AJ
    Eur J Drug Metab Pharmacokinet; 1988; 13(2):113-21. PubMed ID: 3208790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.